ARTIS Ventures is a leading early-stage venture capital firm in San Francisco, pioneering investments at the intersection of life sciences and computer sciences — what we call TechBio.
TechBio®
Over the past 15 years, Computer Science has seen tremendous progress in storage, networking, data analysis and computation power. The field of Life Science has also made tremendous strides in our understanding of biological processes and disease, leading to new therapies.
ARTIS invests at the convergence of these two industry trends. Investment focus areas include AI Drug Discovery, Synthetic Biology, Gene Editing, Digital Health, and more.
ARTIS Fellows will work closely with our investment team in due diligence, deal sourcing, and portfolio support.
Take part in shaping our year-long Fellows Program
Commit 10 hours per month remotely
Receive a competitive monthly stipend
Work directly with impactful healthcare startups
Learn about new cutting edge technologies on the TechBio frontier
Gain VC experience during a record setting market (2021: $86B+ invested in healthcare startups and $28B+ raised by healthcare VCs)
Why Join
Who Should Apply
Applicants should be currently enrolled in a PhD or MD program (or Post-Doc / Residency). Expertise or interest in one of the following areas is preferred:
01
Cell & Gene Therapy
02
Immunology
03
AI / Machine Learning
04
Data Science
05
Genetics
06
Neuroscience
07
Synthetic Biology
08
Digital Health
Applications for 2022 Now Closed
Upon acceptance, AV Fellows will commence their year long commitment.
Please contact Megan Daugherty at md@av.co if you would like to stay informed on future opportunities.
Artis Ventures is committed to increasing opportunities for underrepresented groups, promoting gender, racial, and ethnic diversity in the venture industry.
© Artis Ventures. All rights reserved.